Advertisement

PharmacoEconomics & Outcomes News

, Volume 828, Issue 1, pp 28–28 | Cite as

Prophylactic aprepitant cost effective but not fosaprepitant

Clinical study
  • 3 Downloads

Reference

  1. Kashiwa M, et al. Comparative Cost-utility Analysis Between Aprepitant- and Fosaprepitant-containing Regimens To Prevent Chemotherapy-induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy in Japan. Clinical Therapeutics : 26 Apr 2019. Available from: URL: http://doi.org/10.1016/j.clinthera.2019.03.011

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations